RxDoctor Payments Data

Kadhim Al Banaa, MD

Hematology & Oncology · San Diego, CANPI 1548790041

Payments from drug & device makers

$4,190in general payments, 2019–2025

Across 25 payments — averaging $167.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$2K
  • E.r. Squibb & Sons, L.L.C.$331
  • Amgen$307
  • Lilly USA, LLC$245
  • Pharmaessentia USA Corporation$141
  • Gilead$125
  • plus $597 from 9 others

What the payments were for

  • Consulting fees$2,30055%
  • Food & beverage$1,58938%
  • Education$3007%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,190 in reported general payments places this provider in the 40th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Medicare billing

Part B allowed, 2024
$6,177
Medicare patients
37
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →